Drug intelligence / Profile preview

ceftriaxone and placebo

Development stage
Unknown
Lead developer
Roche
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Ceftriaxone is a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, meningitis, gonorrhea, pelvic inflammatory disease, sepsis, and as prophylaxis before certain surgeries. It acts by inhibiting the synthesis of the bacterial cell wall through binding to penicillin-binding proteins (PBPs), leading to defective cell walls and bacterial death. Ceftriaxone is administered intravenously or intramuscularly due to poor oral bioavailability. Placebo refers to an inert substance with no therapeutic effect; in clinical trials "placebo + ceftriaxone" would refer to a combination arm where both are administered for comparison or blinding purposes[1][3][5].

Brand names
Rocephin
02

Targets

PBP2B (Penicillin-binding protein 2B)

Beyond the preview

Go deeper on ceftriaxone and placebo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ceftriaxone and placebo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call